Next week, a federal advisory committee is set to review a proposal to use CRISPR—the cheap, powerful and buzzy gene-editing tool—on human patients for the first time.
Using the CRISPR gene-editing tool, scientists from Harvard University have developed a technique that permanently records data into living cells. Incredibly, the information imprinted onto these microorganisms can be passed down to the next generation.
Leveraging the pre-existing power of CRISPR, a team of researchers has made an important adjustment to the groundbreaking gene-editing tool that could make it precise enough for human applications.
A mushroom that’s resistant to browning has become the first CRISPR-edited food to get green lit by the US government. Here’s how this mutated fungus managed to escape USDA oversight—and why this agency needs to upgrade its regulatory guidelines.
Just one year after scientists in China made history by modifying the DNA of human embryos, a second team of Chinese researchers has done it again. Using CRISPR/Cas9, the researchers introduced HIV-resistance into the embryos, showcasing the tremendous potential for gene-editing.
Scientists are excited about the prospect of using CRISPR, a powerful gene-editing tool, to combat HIV. A discouraging follow-up study shows that HIV is capable of developing a resistance to the genetic attack—but scientists say CRISPR’s battle with HIV is far from over.
Researchers from Temple University have used the CRISPR/Cas9 gene editing tool to clear out the entire HIV-1 genome from a patient’s infected immune cells. It’s a remarkable achievement that could have profound implications for the treatment of AIDS and other retroviruses.
Mimiviruses are viruses so big they can actually be seen with a simple light microscope. European scientists have now learned that these bizarre organisms have their own immune system that makes them virtually invulnerable to predatory viruses, suggesting these creatures may actually represent a new branch in the tree…
America is a leader in biomedical research and medicine, and much of the fiscal fuel behind that research comes from the government funding the National Institutes of Health (NIH) and the National Science Foundation (NSF). Sure, scientific funding impacts our ability to understand myriad health conditions and figure…
Zika is now a global emergency, and the latest in a long string of mosquito-borne viruses to afflict humanity. Mosquitoes truly suck, and the time has come to do something about them. Here’s how science will help—and why a war on mosquitoes doesn’t mean we have to wipe them off the face of the planet.
Less than a year after scientists in China became the first to genetically modify human embryos, a research team in Britain has been given the green light to perform similar work. It’s a huge moment in biotech history—one that could eventually lead to “designer babies.”
For the first time ever, scientists have used the CRISPR gene-editing tool to successfully treat a genetic muscle disorder in a living adult mammal. It’s a promising medical breakthrough that could soon lead to human therapies.
As we consider the ethics of human gene editing, we need to understand what can and can’t be meaningfully edited.
Researchers in China are reportedly the first to use a powerful gene editing tool to produce super-muscled dogs. The goal is to create test subjects that mimic degenerative human diseases, but the breakthrough also raises the prospect of customized pets.
Editas Medicine hopes to use CRISPR—a revolutionary new gene-editing technology—to treat conditions such as sickle-cell anemia, cancer, and cystic fibrosis.
The fear of genetically-modified creatures escaping from the lab is the basis for a thousand sci-fi stories, but it’s also a legitimate concern. That’s why genetic engineers are inventing kill switches, or genetically-encoded suicide triggers, for GMOs they want to keep contained. Here’s how they work.
CRISPR, a new genome editing tool, could transform the field of biology—and a recent study on genetically-engineered human embryos has converted this promise into media hype. But scientists have been tinkering with genomes for decades. Why is CRISPR suddenly such a big deal?